Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02514668
Title A Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of Isatuximab in Patients With Multiple Myeloma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Sanofi
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Investigational Site Number 840003 Scottsdale Arizona 85054 United States Details
Investigational Site Number 840004 San Francisco California 94117 United States Details
Investigational Site Number 840011 Detroit Michigan 48201 United States Details
Investigational Site Number 840015 Saint Louis Missouri 63110 United States Details
Investigational Site Number 840005 Hackensack New Jersey 07601 United States Details
Investigational Site Number 840010 Durham North Carolina 27707 United States Details
Investigational Site Number 840013 Canton Ohio 44718 United States Details
Investigational Site Number 840001 Nashville Tennessee 37232 United States Details
Investigational Site Number 840002 Salt Lake City Utah 84112-5550 United States Details
Investigational Site Number 840006 Milwaukee Wisconsin 53226 United States Details
Investigational Site Number 203002 Brno 62500 Czechia Details
Investigational Site Number 203001 Praha 2 12808 Czechia Details
Investigational Site Number 250008 Creteil Cedex 94010 France Details
Investigational Site Number 250005 Montpellier Cedex 5 34295 France Details
Investigational Site Number 250002 Nantes Cedex 01 44093 France Details
Investigational Site Number 250004 Pessac 33600 France Details
Investigational Site Number 250001 Poitiers 86021 France Details
Investigational Site Number 250006 Vandoeuvre-Les-Nancy Cedex 54511 France Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field